- Home
- ITCI vs FCN Comparison
ITCI vs FCN Comparison
Compare ITCI & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- FCN
- Stock Information
- Founded
- ITCI 2002
- FCN 1982
- Country
- ITCI United States
- FCN United States
- Employees
- ITCI N/A
- FCN N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- FCN Professional Services
- Sector
- ITCI Health Care
- FCN Consumer Discretionary
- Exchange
- ITCI Nasdaq
- FCN Nasdaq
- Market Cap
- ITCI 8.0B
- FCN 7.2B
- IPO Year
- ITCI N/A
- FCN 1996
- Fundamental
- Price
- ITCI $84.69
- FCN $199.58
- Analyst Decision
- ITCI Strong Buy
- FCN Strong Buy
- Analyst Count
- ITCI 12
- FCN 1
- Target Price
- ITCI $97.67
- FCN $275.00
- AVG Volume (30 Days)
- ITCI 747.9K
- FCN 282.1K
- Earning Date
- ITCI 10-30-2024
- FCN 10-24-2024
- Dividend Yield
- ITCI N/A
- FCN N/A
- EPS Growth
- ITCI N/A
- FCN 28.86
- EPS
- ITCI N/A
- FCN 8.71
- Revenue
- ITCI $613,728,000.00
- FCN $3,728,412,000.00
- Revenue This Year
- ITCI $48.25
- FCN $7.62
- Revenue Next Year
- ITCI $38.47
- FCN $5.01
- P/E Ratio
- ITCI N/A
- FCN $22.81
- Revenue Growth
- ITCI 46.08
- FCN 11.66
- 52 Week Low
- ITCI $58.14
- FCN $185.93
- 52 Week High
- ITCI $93.45
- FCN $243.60
- Technical
- Relative Strength Index (RSI)
- ITCI 55.47
- FCN 39.61
- Support Level
- ITCI $81.83
- FCN $194.15
- Resistance Level
- ITCI $86.36
- FCN $199.96
- Average True Range (ATR)
- ITCI 2.47
- FCN 3.90
- MACD
- ITCI -0.76
- FCN 0.56
- Stochastic Oscillator
- ITCI 30.64
- FCN 38.01
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About FCN FTI Consulting Inc.
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance and restructuring, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.